← All trials
NCT01787188
Phase 3Interventional
Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 1, 2013
- Primary completion
- Oct 1, 2013
- Completion date
- Oct 1, 2013
- First posted
- —
- Last posted
- —
- Enrollment
- 403
- Arms / groups
- 3 / —
- Source
- AACT · pre-existing
Sponsors
- IrokoLead sponsor
- Achieve Clinical Research, LLCOverall official - principal investigator
- Well Pharma Medical Research CorporationOverall official - principal investigator
- Office of Matthew Barton, MDOverall official - principal investigator
- Beacon Clinical Research, LLCOverall official - principal investigator
- Clinical Investigations of Texas, LLCOverall official - principal investigator
- Charlottesville Medical Research Center, LLCOverall official - principal investigator
- Hypothetest, LLCOverall official - principal investigator
- Fleming Island Center for Clinical ResearchOverall official - principal investigator
- Heartland Research Associates, LLCOverall official - principal investigator
- Avail Clinical ResearchOverall official - principal investigator
- Quality Research IncOverall official - principal investigator
- Triad Clinical ResearchOverall official - principal investigator
- Altoona Center for Clinical ResearchOverall official - principal investigator
- Professional Research Network of Kansas, LLCOverall official - principal investigator
- Drug Trials AmericaOverall official - principal investigator
- Sterling Research Group, LtdOverall official - principal investigator
- Medical Research Associates, IncOverall official - principal investigator
- Wells Institute for Health AwarenessOverall official - principal investigator
- Peninsula Research, IncOverall official - principal investigator
- Palmetto Clinical Trial Services, LLCOverall official - principal investigator
- Westside Center for Clinical ResearchOverall official - principal investigator
- Clinical Trials Technology IncOverall official - principal investigator
- Sundance Clinical Research, LLCOverall official - principal investigator
- Arroyo Medical Group, IncOverall official - principal investigator
- Jacksonville Center for Clinical ResearchOverall official - principal investigator
- Premier Research GroupOverall official - principal investigator
- Meridien ResearchOverall official - principal investigator
- Radiant ResearchOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.